time due to Position Statements issued by the EASD and the ADA. However, this approach needs further refining to encompass recent studies that focus on CV efficacy of at least 2 classes of drugs and newer discoveries made using gut microbiome and brain as possible new targets. Our approach has now moved beyond a simple menu of drugs and must incorporate new potential approaches.